Increasing angiotensin-(1-7) levels in the brain attenuates metabolic syndrome-related risks in fructose-fed rats

Keyphrases

• Abdominal Adipose Tissue 28%
• Angiotensin-(1-7) 100%
• Baroreflex Sensitivity 28%
• Beneficial Role 14%
• Cardiac Sympathetic Activity 28%
• Cardiovascular Disease 14%
• Cardiovascular Parameters 14%
• Chronic Intracerebroventricular Infusion 28%
• Continued Access 14%
• Dorsomedial Medulla 14%
• Drinking Water 14%
• Fructose 85%
• Fructose Intake 14%
• Fructose-fed Rats 100%
• Glucose Level 14%
• Glucose Tolerance 14%
• Glucose-6-phosphatase (G6Pase) 14%
• Glycogen Content 28%
• Hepatic Glycogen 14%
• Hyperleptinemia 14%
• Hypothalamus 14%
• Impaired Glucose Tolerance 14%
• Insulin 14%
• Insulin Level 14%
• Intracerebroventricular Injection 14%
• Leptin 14%
• Liver 57%
• Mean Arterial Pressure 28%
• Metabolic Disorders 14%
• Metabolic Parameters 14%
• Metabolic Syndrome 100%
• MRNA Expression 28%
• Muscle Glycogen 14%
• N-methyl-D-aspartate Receptor (NMDAR) 14%
• Neuronal Nitric Oxide Synthase (nNOS) 14%
• Normalized Mean 14%
• NR1 Subunit 14%
• Phosphoenolpyruvate Carboxylase 14%
• Relative Weight 42%
• Sensitivity Threshold 14%
• Seven-level 100%
• Sprague-Dawley Rats 14%
• Sympathetic Tone 28%
• Triglycerides 14%

Pharmacology, Toxicology and Pharmaceutical Science

• angiotensin[1-7] 100%
• Aspartic Acid 7%
• Cardiovascular Disease 7%
• Fructose 100%
• Glucose 6 Phosphatase 7%
• Hyperleptinemia 7%
• Impaired Glucose Tolerance 7%
• Leptin 7%
• Metabolic Disorder 7%
• Metabolic Syndrome X 100%
• Neuronal Nitric Oxide Synthase 7%
• Phosphoenolpyruvate Carboxykinase (GTP) 7%
• Receptor 7%
• Sprague Dawley Rat 7%
• Triacylglycerol 7%